SEARCH

SEARCH BY CITATION

References

  • 1
    Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 15001511.
  • 2
    Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117: 632639.
  • 3
    Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20: 119.
  • 4
    Schwesinger WH, Kurtin WE, Levine BA, Page CP. Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation. Ann Surg 1985; 201: 319322.
  • 5
    Acalovschi M, Badea R, Dumitrascu D, Varga C. Prevalence of gallstones in liver cirrhosis: a sonographic survey. Am J Gastroenterol 1988; 83: 954956.
  • 6
    Fornari F, Civardi G, Buscarini E, Cavanna L, Imberti D, Rossi S, et al. Cirrhosis of the liver: a risk factor for development of cholelithiasis in males. Dig Dis Sci 1990; 35: 14031408.
  • 7
    Iber FL, Caruso G, Polepalle C, Kuchipudi V, Chinoy M. Increasing prevalence of gallstones in male veterans with alcoholic cirrhosis. Am J Gastroenterol 1990; 85: 15931596.
  • 8
    Conte D, Barisani D, Mandelli C, Bodini P, Borzio M, Pistoso S, et al. Cholelithiasis in cirrhosis: analysis of 500 cases. Am J Gastroenterol 1991; 86: 16291632.
  • 9
    Acalovschi M, Badea R, Pascu M. Incidence of gallstones in liver cirrhosis. Am J Gastroenterol 1991; 86: 11791181.
  • 10
    Fornari F, Imberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, et al. Incidence of gallstones in a population of patients with cirrhosis. J Hepatol 1994; 20: 797801.
  • 11
    Poynard T, Lonjon I, Mathurin P, Abella A, Musset D, Bedossa P, et al. Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AII. Alcohol Clin Exp Res 1995; 19: 7580.
  • 12
    Castellano L, De Sio I, Silvestrino F, Marmo R, Del Vecchio Blanco C. Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors. Ital J Gastroenterol 1995; 27: 425429.
  • 13
    Genzini T, de Miranda MP, de Oliveira e Silva A, de Souza CP, Silva FA, de Melo CR, et al. Cholelithiasis in cirrhotic patients. (Analysis of cholelithiasis among patients with liver cirrhosis in Sao Paulo, Brazil). Arq Gastroenterol 1996; 33: 5259.
  • 14
    Benvegnu L, Noventa F, Chemello L, Fattovich G, Alberti A. Prevalence and incidence of cholecystolithiasis in cirrhosis and relation to the etiology of liver disease. Digestion 1997; 58: 293298.
  • 15
    del Olmo JA, Garcia F, Serra MA, Maldonado L, Rodrigo JM. Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol 1997; 32: 10611065.
  • 16
    Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. HEPATOLOGY 1997; 26: 809818.
  • 17
    Maggi A, Solenghi D, Panzeri A, Borroni G, Cazzaniga M, Sangiovanni A, et al. Prevalence and incidence of cholelithiasis in patients with liver cirrhosis. Ital J Gastroenterol Hepatol 1997; 29: 330335.
  • 18
    Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med 1999; 159: 4952.
  • 19
    Elzouki AN, Nilsson S, Nilsson P, Verbaan H, Simanaitis M, Lindgren S. The prevalence of gallstones in chronic liver disease is related to degree of liver dysfunction. Hepatogastroenterology 1999; 46: 29462950.
  • 20
    Li CP, Hwang SJ, Lee FY, Chang FY, Lin HC, Lu RH et al. Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. Dig Dis Sci 2000; 45: 11091114.
  • 21
    Buchner AM, Sonnenberg A. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. Am J Gastroenterol 2002; 97: 905909.
    Direct Link:
  • 22
    Acalovschi M, Blendea D, Feier C, Letia AI, Ratiu N, Dumitrascu DL, et al. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study. Am J Gastroenterol 2003; 98: 18561860.
  • 23
    Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47: 139.
  • 24
    National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002—June 10–12, 2002. HEPATOLOGY 2002; 36(Suppl): S3S20.
  • 25
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556562.
  • 26
    National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Vital Health Stat 1 1994; 32: 1407.
  • 27
    Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163: 218224.
  • 28
    Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999; 27: 17.
  • 29
    Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. HEPATOLOGY 1987; 7: 913917.
  • 30
    Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. HEPATOLOGY 2002; 35: 15071512.
  • 31
    Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993; 119: 10291035.
  • 32
    Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med 1998; 128: 417425.
  • 33
    Maringhini A, Ciambra M, Baccelliere P, Raimondo M, Orlando A, Tine F, et al. Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med 1993; 119: 116120.
  • 34
    Uhler ML, Marks JW, Judd HL. Estrogen replacement therapy and gallbladder disease in postmenopausal women. Menopause 2000; 7: 162167.
  • 35
    Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 1993; 83: 11131120.
  • 36
    Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. HEPATOLOGY 2000; 31: 299303.
  • 37
    Leitzmann MF, Tsai CJ, Stampfer MJ, Rimm EB, Colditz GA, Willett WC, et al. Alcohol consumption in relation to risk of cholecystectomy in women. Am J Clin Nutr 2003; 78: 339347.
  • 38
    Leitzmann MF, Willett WC, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA 1999; 281: 21062112.
  • 39
    Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 2002; 123: 18231830.
  • 40
    Sarin SK, Negi VS, Dewan R, Sasan S, Saraya A. High familial prevalence of gallstones in the first-degree relatives of gallstone patients. HEPATOLOGY 1995; 22: 138141.
  • 41
    Diehl AK, Schwesinger WH, Holleman DR Jr, Chapman JB, Kurtin WE. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones. Am J Gastroenterol 1995; 90: 967972.
  • 42
    Lai SW, Ng KC. Risk factors for gallstone disease in a hospital-based study. South Med J 2002; 95: 14191423.
  • 43
    O'Sullivan MJ, Evoy D, O'Donnell C, Rajpal PK, Cannon B, Kenny-Walsh L, et al. Gallstones and laparoscopic cholecystectomy in hepatitis C patients. Ir Med J 2001; 94: 114117.
  • 44
    Alvaro D, Angelico M, Gandin C, Ginanni CS, Capocaccia L. Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis. J Hepatol 1990; 10: 228234.
  • 45
    Acalovschi M, Dumitrascu DL, Csakany I. Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis—a simultaneous sonographic study. Gut 1997; 40: 412417.
  • 46
    Chawla A, Puthumana L, Thuluvath PJ. Autonomic dysfunction and cholelithiasis in patients with cirrhosis. Dig Dis Sci 2001; 46: 495498.
  • 47
    Stauber RE, Rosenblum E, Eagon PK, Gavaler JS, Van Thiel DH. The effect of portal-systemic shunting on hepatic sex hormone receptors in male rats. Gastroenterology 1991; 100: 168174.
  • 48
    Loriot MA, Bronowicki JP, Lagorce D, Lakehal F, Persico T, Barba G, et al. Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. HEPATOLOGY 1999; 29: 15871595.
  • 49
    Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6: 805811.
  • 50
    Puggioni A, Wong LL. A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis. J Am Coll Surg 2003; 197: 921926.